Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of Long-Term Care Facilities in the VIVALDI study
View ORCID ProfileOliver Stirrup, Madhumita Shrotri, Natalie L. Adams, View ORCID ProfileMaria Krutikov, Borscha Azmi, Igor Monakhov, View ORCID ProfileGokhan Tut, View ORCID ProfilePaul Moss, View ORCID ProfileAndrew Hayward, View ORCID ProfileAndrew Copas, View ORCID ProfileLaura Shallcross
doi: https://doi.org/10.1101/2023.03.01.23286627
Oliver Stirrup
1Institute for Global Health, University College London, London, UK
Madhumita Shrotri
2UCL Institute of Health Informatics, London, UK
Natalie L. Adams
2UCL Institute of Health Informatics, London, UK
Maria Krutikov
2UCL Institute of Health Informatics, London, UK
Borscha Azmi
2UCL Institute of Health Informatics, London, UK
Igor Monakhov
3UK Health Security Agency, London, UK
Gokhan Tut
4Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Paul Moss
4Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Andrew Hayward
5UCL Institute of Epidemiology & Healthcare, London, UK
6Health Data Research UK, London, UK
Andrew Copas
1Institute for Global Health, University College London, London, UK
Laura Shallcross
2UCL Institute of Health Informatics, London, UK
Data Availability
De-identified test results and limited meta-data will be made available for use by researchers in future studies, subject to appropriate research ethical approvals, once the VIVALDI study cohort has been finalised.
Posted March 03, 2023.
Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of Long-Term Care Facilities in the VIVALDI study
Oliver Stirrup, Madhumita Shrotri, Natalie L. Adams, Maria Krutikov, Borscha Azmi, Igor Monakhov, Gokhan Tut, Paul Moss, Andrew Hayward, Andrew Copas, Laura Shallcross
medRxiv 2023.03.01.23286627; doi: https://doi.org/10.1101/2023.03.01.23286627
Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of Long-Term Care Facilities in the VIVALDI study
Oliver Stirrup, Madhumita Shrotri, Natalie L. Adams, Maria Krutikov, Borscha Azmi, Igor Monakhov, Gokhan Tut, Paul Moss, Andrew Hayward, Andrew Copas, Laura Shallcross
medRxiv 2023.03.01.23286627; doi: https://doi.org/10.1101/2023.03.01.23286627
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2827)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12527)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4407)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2836)
- Health Policy (1044)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4161)
- Nursing (220)
- Nutrition (615)
- Oncology (2191)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (264)
- Palliative Medicine (81)
- Pathology (484)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6744)
- Radiology and Imaging (1483)
- Respiratory Medicine (896)
- Rheumatology (429)
- Sports Medicine (362)
- Surgery (471)
- Toxicology (57)
- Transplantation (198)
- Urology (173)